These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 25697595)

  • 41. The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease.
    Rysz J; Gluba-Brzózka A; Rysz-Górzyńska M; Franczyk B
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963445
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between TG/HDL-C ratio and metabolic syndrome risk factors with chronic kidney disease in healthy adult population.
    Ho CI; Chen JY; Chen SY; Tsai YW; Weng YM; Tsao YC; Li WC
    Clin Nutr; 2015 Oct; 34(5):874-80. PubMed ID: 25304295
    [TBL] [Abstract][Full Text] [Related]  

  • 43. iTRAQ-based proteomic analysis of plasma reveals abnormalities in lipid metabolism proteins in chronic kidney disease-related atherosclerosis.
    Luczak M; Formanowicz D; Marczak Ł; Suszyńska-Zajczyk J; Pawliczak E; Wanic-Kossowska M; Stobiecki M
    Sci Rep; 2016 Sep; 6():32511. PubMed ID: 27600335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University Hospital.
    Sangsawang T; Sriwijitkamol A
    Vasc Health Risk Manag; 2015; 11():563-7. PubMed ID: 26604773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-HDL-cholesterol to HDL-cholesterol ratio as an independent risk factor for the development of chronic kidney disease.
    Zuo PY; Chen XL; Liu YW; Zhang R; He XX; Liu CY
    Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):582-7. PubMed ID: 25921842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pattern of dyslipidemia and evaluation of non-HDL cholesterol as a marker of risk factor for cardiovascular disease in type 2 diabetes mellitus.
    Pandeya A; Sharma M; Regmi P; Basukala A; Lamsal M
    Nepal Med Coll J; 2012 Dec; 14(4):278-82. PubMed ID: 24579534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Statins: what is their place in the treatment of chronic kidney insufficiency?].
    Ponte B; Bourquin V; Stoermann-Chopard C
    Rev Med Suisse; 2009 Feb; 5(192):463-4, 466-8. PubMed ID: 19317313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deeper insight into chronic kidney disease-related atherosclerosis: comparative proteomic studies of blood plasma using 2DE and mass spectrometry.
    Luczak M; Formanowicz D; Marczak Ł; Pawliczak E; Wanic-Kossowska M; Figlerowicz M; Stobiecki M
    J Transl Med; 2015 Jan; 13():20. PubMed ID: 25622820
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients.
    Kanbay M; Yilmaz MI; Apetrii M; Saglam M; Yaman H; Unal HU; Gok M; Caglar K; Oguz Y; Yenicesu M; Cetinkaya H; Eyileten T; Acikel C; Vural A; Covic A
    Am J Nephrol; 2012; 36(3):228-37. PubMed ID: 22948239
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic syndrome and chronic kidney disease.
    Belarbia A; Nouira S; Sahtout W; Guedri Y; Achour A
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):931-40. PubMed ID: 26354564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Abnormal high-density lipoproteins in overweight adolescents with atherogenic dyslipidemia.
    Medina-Urrutia A; Juarez-Rojas JG; Cardoso-Saldaña G; Jorge-Galarza E; Posadas-Sánchez R; Martínez-Alvarado R; Caracas-Portilla N; Mendoza Pérez E; Posadas-Romero C
    Pediatrics; 2011 Jun; 127(6):e1521-7. PubMed ID: 21555497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Atherogenic dyslipidemia, underdiagnosed factor for cardiovascular complications].
    Aray-Andrade MM; López-Montanero EE; Preciado-Gómez JA
    Salud Publica Mex; 2018; 60(4):381-382. PubMed ID: 30137933
    [No Abstract]   [Full Text] [Related]  

  • 53. Serum magnesium level and vascular stiffness in children with chronic kidney disease on regular hemodialysis.
    Zaher MM; Abdel-Salam M; Abdel-Salam R; Sabour R; Morsy AA; Gamal D
    Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):233-40. PubMed ID: 26997375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proteinuria-associated renal magnesium wasting leads to hypomagnesemia: a common electrolyte abnormality in chronic kidney disease.
    Oka T; Hamano T; Sakaguchi Y; Yamaguchi S; Kubota K; Senda M; Yonemoto S; Shimada K; Matsumoto A; Hashimoto N; Mori D; Monden C; Takahashi A; Obi Y; Yamamoto R; Takabatake Y; Kaimori JY; Moriyama T; Horio M; Matsui I; Isaka Y
    Nephrol Dial Transplant; 2019 Jul; 34(7):1154-1162. PubMed ID: 29796601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study.
    Viazzi F; Garneri D; Leoncini G; Gonnella A; Muiesan ML; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Trimarco B; Volpe M; Agabiti Rosei E; Deferrari G; Pontremoli R
    Nutr Metab Cardiovasc Dis; 2014 Aug; 24(8):921-7. PubMed ID: 24675005
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between dyslipidemia and chronic kidney disease: a cross-sectional study in the middle-aged and elderly Chinese population.
    Liu DW; Wan J; Liu ZS; Wang P; Cheng GY; Shi XZ
    Chin Med J (Engl); 2013 Apr; 126(7):1207-12. PubMed ID: 23557545
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between serum magnesium and risk factors of cardiovascular disease in hemodialysis patients.
    Khatami MR; Mirchi E; Khazaeipour Z; Abdollahi A; Jahanmardi A
    Iran J Kidney Dis; 2013 Jan; 7(1):47-52. PubMed ID: 23314142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The MAURO study: baseline characteristics and compliance with guidelines targets.
    Leonardis D; Mallamaci F; Enia G; Postorino M; Tripepi G; Zoccali C;
    J Nephrol; 2012; 25(6):1081-90. PubMed ID: 23172127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apolipoprotein M in patients with chronic kidney disease.
    Sørensen IM; Bertelsen M; Freese E; Lindhard K; Ullum H; Feldt-Rasmussen B; Nielsen LB; Christoffersen C; Bro S
    Atherosclerosis; 2018 Aug; 275():304-311. PubMed ID: 29980057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early intervention strategies to lower cardiovascular risk in early nephropathy: focus on dyslipidemia.
    Sorrentino MJ
    Cardiol Clin; 2010 Aug; 28(3):529-39. PubMed ID: 20621255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.